517 related articles for article (PubMed ID: 21712410)
21. Expression of embryonal stem cell transcription factors in breast cancer: Oct4 as an indicator for poor clinical outcome and tamoxifen resistance.
Gwak JM; Kim M; Kim HJ; Jang MH; Park SY
Oncotarget; 2017 May; 8(22):36305-36318. PubMed ID: 28422735
[TBL] [Abstract][Full Text] [Related]
22. Spheroid body-forming cells in the human gastric cancer cell line MKN-45 possess cancer stem cell properties.
Liu J; Ma L; Xu J; Liu C; Zhang J; Liu J; Chen R; Zhou Y
Int J Oncol; 2013 Feb; 42(2):453-9. PubMed ID: 23229446
[TBL] [Abstract][Full Text] [Related]
23. In vitro propagation and characterization of neoplastic stem/progenitor-like cells from human prostate cancer tissue.
Guzmán-Ramírez N; Völler M; Wetterwald A; Germann M; Cross NA; Rentsch CA; Schalken J; Thalmann GN; Cecchini MG
Prostate; 2009 Nov; 69(15):1683-93. PubMed ID: 19644960
[TBL] [Abstract][Full Text] [Related]
24. Expression of the embryonic stem cell marker SOX2 in early-stage breast carcinoma.
Lengerke C; Fehm T; Kurth R; Neubauer H; Scheble V; Müller F; Schneider F; Petersen K; Wallwiener D; Kanz L; Fend F; Perner S; Bareiss PM; Staebler A
BMC Cancer; 2011 Jan; 11():42. PubMed ID: 21276239
[TBL] [Abstract][Full Text] [Related]
25. Two-stage induced differentiation of OCT4+/Nanog+ stem-like cells in lung adenocarcinoma.
Li R; Huang J; Ma M; Lou Y; Zhang Y; Wu L; Chang DW; Zhao P; Dong Q; Wu X; Han B
Oncotarget; 2016 Oct; 7(42):68360-68370. PubMed ID: 27588392
[TBL] [Abstract][Full Text] [Related]
26. Reprogramming of prostate cancer-associated stromal cells to embryonic stem-like.
Vêncio EF; Nelson AM; Cavanaugh C; Ware CB; Milller DG; Garcia JC; Vêncio RZ; Loprieno MA; Liu AY
Prostate; 2012 Sep; 72(13):1453-63. PubMed ID: 22314551
[TBL] [Abstract][Full Text] [Related]
27. Human embryonic and neuronal stem cell markers in retinoblastoma.
Seigel GM; Hackam AS; Ganguly A; Mandell LM; Gonzalez-Fernandez F
Mol Vis; 2007 Jun; 13():823-32. PubMed ID: 17615543
[TBL] [Abstract][Full Text] [Related]
28. Networks of Transcription Factors for Oct4 Expression in Mice.
Li YQ
DNA Cell Biol; 2017 Sep; 36(9):725-736. PubMed ID: 28731785
[TBL] [Abstract][Full Text] [Related]
29. Epithelial to mesenchymal transition is mechanistically linked with stem cell signatures in prostate cancer cells.
Kong D; Banerjee S; Ahmad A; Li Y; Wang Z; Sethi S; Sarkar FH
PLoS One; 2010 Aug; 5(8):e12445. PubMed ID: 20805998
[TBL] [Abstract][Full Text] [Related]
30. Embryonic stem cells markers SOX2, OCT4 and Nanog expression and their correlations with epithelial-mesenchymal transition in nasopharyngeal carcinoma.
Luo W; Li S; Peng B; Ye Y; Deng X; Yao K
PLoS One; 2013; 8(2):e56324. PubMed ID: 23424657
[TBL] [Abstract][Full Text] [Related]
31. Generation and identification of pluripotent stem cells from human embryonic fibroblast cells by 4 defined factors.
Du L; Lin G; Lu G
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Dec; 34(12):1157-65. PubMed ID: 20045908
[TBL] [Abstract][Full Text] [Related]
32. Expression of pluripotent stem cell reprogramming factors by prostate tumor initiating cells.
Bae KM; Su Z; Frye C; McClellan S; Allan RW; Andrejewski JT; Kelley V; Jorgensen M; Steindler DA; Vieweg J; Siemann DW
J Urol; 2010 May; 183(5):2045-53. PubMed ID: 20303530
[TBL] [Abstract][Full Text] [Related]
33. Reduced tumorigenicity and drug resistance through the downregulation of octamer-binding protein 4 and Nanog transcriptional factor expression in human breast stem cells.
Huang ZJ; You J; Luo WY; Chen BS; Feng QZ; Wu BL; Jiang L; Luo Q
Mol Med Rep; 2015 Mar; 11(3):1647-54. PubMed ID: 25405855
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells.
Xu N; Papagiannakopoulos T; Pan G; Thomson JA; Kosik KS
Cell; 2009 May; 137(4):647-58. PubMed ID: 19409607
[TBL] [Abstract][Full Text] [Related]
35. Transcription factor decoy against stem cells master regulators, Nanog and Oct-4: a possible approach for differentiation therapy.
Rad SM; Bamdad T; Sadeghizadeh M; Arefian E; Lotfinia M; Ghanipour M
Tumour Biol; 2015 Apr; 36(4):2621-9. PubMed ID: 25464862
[TBL] [Abstract][Full Text] [Related]
36. Continuous hypoxic culturing of human embryonic stem cells enhances SSEA-3 and MYC levels.
Närvä E; Pursiheimo JP; Laiho A; Rahkonen N; Emani MR; Viitala M; Laurila K; Sahla R; Lund R; Lähdesmäki H; Jaakkola P; Lahesmaa R
PLoS One; 2013; 8(11):e78847. PubMed ID: 24236059
[TBL] [Abstract][Full Text] [Related]
37. The inhibitory effect of hypoxic cytotoxin on the expansion of cancer stem cells in ovarian cancer.
Nozawa-Suzuki N; Nagasawa H; Ohnishi K; Morishige K
Biochem Biophys Res Commun; 2015 Feb; 457(4):706-11. PubMed ID: 25619133
[TBL] [Abstract][Full Text] [Related]
38. Generation of human-induced pluripotent stem cells from gut mesentery-derived cells by ectopic expression of OCT4/SOX2/NANOG.
Li Y; Zhao H; Lan F; Lee A; Chen L; Lin C; Yao Y; Li L
Cell Reprogram; 2010 Jun; 12(3):237-47. PubMed ID: 20698766
[TBL] [Abstract][Full Text] [Related]
39. Silencing of core transcription factors in human EC cells highlights the importance of autocrine FGF signaling for self-renewal.
Greber B; Lehrach H; Adjaye J
BMC Dev Biol; 2007 May; 7():46. PubMed ID: 17506876
[TBL] [Abstract][Full Text] [Related]
40. Generation of tumor-initiating cells by exogenous delivery of OCT4 transcription factor.
Beltran AS; Rivenbark AG; Richardson BT; Yuan X; Quian H; Hunt JP; Zimmerman E; Graves LM; Blancafort P
Breast Cancer Res; 2011 Sep; 13(5):R94. PubMed ID: 21952072
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
